In regard to BAX expression, a few studies have addressed the issue of its clinical significance in advanced stage ovarian carcinomas; however, associations with CR or DFS have not been observed (Marx et al, 1997; Baekelandt et al, 2000; Sengupta et al, 2000; Schuyer et al, 2001). This evidence concerns the gene BAX and ovarian carcinoma.